Candlewood Partners (“Candlewood”), a middle market investment bank with a proven track record advising secured lenders, private credit funds, and companies through complex restructurings and special situations, is pleased to announce its role as sole financial advisor to the Senior Lender in connection with the sale of substantially all of the assets of Operio Group LLC (“Operio” or the “Company”) and its subsidiaries. The disposition was conducted pursuant to Article 9 of the Uniform Commercial Code and completed through a competitive sale process that culminated in a sale to a consortium of strategic buyers.
Operio is a global supplier to the pharmaceutical, nutraceutical, and dietary supplement manufacturing markets, providing tablet press machinery, precision tableting tooling, replacement parts, and consumable products to producers worldwide. The Company’s operations span numerous tablet press and equipment-manufacturing subsidiaries as well as ingredients and distribution businesses, serving a diversified base of customers across North America, the United Kingdom, and international end markets.
The Article 9 disposition provided an efficient mechanism to preserve the going-concern value of Operio’s operating businesses, maintain continuity for customers and employees, and maximize recovery for the Lender.
“The Operio process demonstrated both the depth of strategic interest in these businesses and the effectiveness of a well-run Article 9 sale in preserving enterprise value. We are pleased to have helped our client achieve a successful outcome that maximized principal recovery while positioning the acquired businesses to continue operating under new ownership.”
— Rishi Agarwal, Director, Candlewood Partners
This transaction underscores Candlewood’s specialized expertise in Article 9 dispositions, lender services, and distressed M&A, and its ability to guide secured lenders and other stakeholders through complex special situations from strategy through execution.
ABOUT OPERIO GROUP
Operio Group LLC is a global supplier to the pharmaceutical, nutraceutical, and dietary supplement manufacturing industries, offering tablet press machinery, precision tableting tooling, replacement parts, and consumable products. Through its family of operating businesses the Company serves manufacturers across North America, the United Kingdom, and international markets.
ABOUT CANDLEWOOD PARTNERS
Candlewood Partners is a Cleveland, Chicago, and South Florida-based boutique investment bank and advisory firm. Our focus is middle market capital raising, restructuring advisory, lender services, and M&A execution. Since 2001, Candlewood has supported the needs of private businesses, small cap public companies, private equity and independent sponsors, and private credit lenders. We leverage decades of experience to maximize value for our clients, successfully navigating complex engagements across diverse industries and markets worldwide.
Contacts
Natan Milgrom, ndm@candlewoodpartners.com 216.472.6647
Rishi Agarwal, ra@candlewoodpartners.com 216.472.6662
Hallie Berk, hmb@candlewoodpartners.com 561.928.0665
Candlewood Partners, LLC
Established 2001
